[Show abstract] [Hide abstract]
ABSTRACT: Oxcarbazepine (OXC) is widely registered for the treatment of partial seizures and generalized tonic-clonic seizures (GTCS). Myoclonic seizures induced by OXC are uncommon. We report a child with idiopathic generalized epilepsy who developed myoclonic seizures and had an abnormal electroencephalogram (EEG) when oral suspension of OXC was introduced. This study suggests that oral suspension of OXC can precipitate myoclonus.
International journal of clinical pharmacology and therapeutics 04/2012; 50(4):300-1. DOI:10.5414/CP201660 · 1.22 Impact Factor